| Detected | Trial | Change |
|---|---|---|
| 2026-08-15 | NCT07040319 Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in… |
date change Primary completion pushed: 2027-10-30 -> 2028-03-03 |
| 2026-08-15 | NCT07040319 Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in… |
date change Completion pushed: 2027-10-30 -> 2028-03-03 |
| 2026-08-14 | NCT07216794 Small Trial of Alendronate Impact on the Reservoir of HIV |
Recruitment opened |
| 2026-08-14 | NCT06863142 Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent… |
date change Primary completion pushed: 2026-07-31 -> 2027-02-09 |
| 2026-08-14 | NCT06863142 Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent… |
date change Completion pushed: 2026-07-31 -> 2027-02-09 |
| 2026-08-13 | NCT00344188 Diagnosis and Treatment of Leishmania Infections |
Primary endpoint(s) modified |
| 2026-08-13 | NCT06871579 Study of the Esophageal String Test (EST) for the Diagnosis of Helicobacter Pylori |
Enrollment closed, study ongoing |
| 2026-08-11 | NCT00050310 Natural History of Anthrax: a Study of Primary Infected, Recovered, and Exposed… |
Trial completed |
| 2026-08-11 | NCT00050310 Natural History of Anthrax: a Study of Primary Infected, Recovered, and Exposed… |
Enrollment reduced: 200 -> 15 participants |
| 2026-08-11 | NCT06918990 Treatment of Antibody-Mediated Rejection (ABMR) With CarBel |
Primary endpoint(s) modified |
| 2026-08-11 | NCT00967785 A Phase I Study of Mozobil in the Treatment of Patients With WHIMS |
Trial completed |
| 2026-08-11 | NCT00967785 A Phase I Study of Mozobil in the Treatment of Patients With WHIMS |
Enrollment reduced: 20 -> 13 participants |
| 2026-08-11 | NCT00967785 A Phase I Study of Mozobil in the Treatment of Patients With WHIMS |
date change Primary completion moved earlier: 2026-12-31 -> 2026-08-06 |
| 2026-08-11 | NCT00967785 A Phase I Study of Mozobil in the Treatment of Patients With WHIMS |
date change Completion moved earlier: 2026-12-31 -> 2026-08-06 |
| 2026-08-11 | NCT02471378 Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of… |
date change Primary completion pushed: 2027-06-30 -> 2028-06-30 |
| 2026-08-08 | NCT01125228 Effectiveness of Zidovudine vs. Zidovudine Plus Alpha Interferon vs. Interferon for… |
Trial completed |
| 2026-08-07 | NCT07569029 A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA… |
Recruitment opened |
| 2026-08-07 | NCT07569029 A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA… |
Trial sites expanded: 11 -> 19 locations |
| 2026-08-05 | NCT06325709 Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked… |
Enrollment increased: 10 -> 15 participants |
| 2026-08-04 | NCT02015013 Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and… |
date change Primary completion pushed: 2026-10-31 -> 2030-10-31 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-11 | NCT07757802 Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Adults | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT00004317 | Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital… | Toxoplasmosis | Recruiting |
| NCT05285891 | Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis | Multiple Sclerosis | Recruiting |
| NCT07199192 | Steroid Treatment for Severe Acute Respiratory Infection (STAR) Trial | Hypoxemia | Not Yet Recruiting |
| Phase 3 | |||
| NCT04047628 | Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple… | Relapsing Multiple Sclerosis | Recruiting |
| NCT03568383 | Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant… | Tuberculosis, MDR | Active, Not Recruiting |
| NCT03164564 | Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to… | HIV Infections | Active, Not Recruiting |
| NCT03635788 | The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE | HIV Infections | Active, Not Recruiting |
| Phase 2 | |||
| NCT05201469 | VIBRANT: VIB4920 for Active Lupus Nephritis | Lupus Nephritis | Recruiting |
| NCT06919003 | Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of… | Kidney Transplant | Recruiting |
| NCT05917522 | Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation | Kidney Transplant | Recruiting |
| NCT05719441 | A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies… | Acute HIV Infection | Recruiting |
| NCT05947071 | High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT)… | Immunization; Infection | Recruiting |
| NCT06055608 | Advancing Transplantation Outcomes in Children | Kidney Transplant | Recruiting |
| NCT05383742 | Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and… | Tuberculous Meningitis | Recruiting |
| NCT07549503 | Early Signals of the Transition From Immune Quiescence to Activation in the Liver… | Liver Transplant | Recruiting |
| NCT05398809 | Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With… | Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced) | Recruiting |
| NCT03835767 | Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With… | Milk and/or Peanut Allergy | Recruiting |
| NCT07015996 | Efficacy of Tezepelumab in Peanut Oral Immunotherapy | Peanut Allergy | Recruiting |
| NCT06477653 | Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response… | Hypereosinophilic Syndrome | Recruiting |
| NCT03949855 | Belimumab With Rituximab for Primary Membranous Nephropathy | Membranous Nephropathy | Recruiting |
| NCT06478017 | Belatacept in Heart Transplantation | Heart Transplant | Recruiting |
| NCT06075745 | Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates | Liver Transplant | Recruiting |
| NCT06280950 | Expanding Liver Transplant Immunosuppression Minimization Via Everolimus | Liver Transplant | Recruiting |
| NCT06033196 | Tocilizumab in Lung Transplantation | Lung Transplant | Recruiting |
| NCT06476132 | Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung… | Lung Transplant | Recruiting |